Drug Shortage Report for TELMISARTAN
| Report ID | 69049 |
| Drug Identification Number | 02390353 |
| Brand name | TELMISARTAN |
| Common or Proper name | TELMISARTAN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2019-01-21 |
| Actual start date | 2019-01-25 |
| Estimated end date | 2019-05-29 |
| Actual end date | 2019-05-29 |
| Shortage status | Resolved |
| Updated date | 2019-05-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.